NCT03117231

Brief Summary

The purpose of this study is to evaluate if anodal tDCS stimulation over M1 may decrease chronic knee OA pain in elderly subjects with defective CPM. In addition, this trial will help to investigate the role of central sensitization in knee OA and evaluate how tDCS stimulation may affect it.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 6, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 17, 2017

Completed
11 months until next milestone

Study Start

First participant enrolled

March 15, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2019

Completed
Last Updated

September 9, 2019

Status Verified

September 1, 2019

Enrollment Period

1.2 years

First QC Date

April 6, 2017

Last Update Submit

September 6, 2019

Conditions

Keywords

osteoarthritiselderlymusculoskeletal paintranscranial direct current stimulation

Outcome Measures

Primary Outcomes (1)

  • Changes in Pain Scale

    Determine whether anodal transcranial direct current stimulation is effective in reducing pain in subjects with chronic pain due to knee osteoarthritis, as measured by changes in the Brief Pain Inventory (BPI)

    Measured at baseline and up to 60 days after the end of stimulation

Secondary Outcomes (13)

  • Changes in Quality of Life

    Measured at baseline, 15, 30 and 60 days after the of stimulation

  • Changes in Physical Function as measured through Lequesne Index

    Measured at baseline, 15, 30, and 60 days after the end of stimulation

  • Changes in Patient Global Assessment

    Measured at baseline, 15, 30 and 60 after the end of stimulation

  • Changes in Physical Function as measured through Western Ontário and McMaster Universities Osteoarthritis Index

    Measured at baseline, 15, 30 and 60 days after the end of stimulation

  • Adverse Events

    Up to 60 days after the end of stimulation

  • +8 more secondary outcomes

Study Arms (2)

Active tDCS

EXPERIMENTAL

Subjects will undergo low-intensity transcranial electrical stimulation for 20 minutes.

Device: Active Transcranial Direct Current Stimulation (tDCS)

Sham tDCS

SHAM COMPARATOR

Subjects will undergo low-intensity transcranial electrical stimulation for 20 minutes.

Device: Sham Transcranial Direct Current Stimulation (tDCS)

Interventions

Subjects will undergo 15 sessions of tDCS stimulation, 1x per day at 20 minutes per session, of up to 2mA. During active stimulation, the current will be active for the full 20 minutes.

Active tDCS

Subjects will undergo 15 sessions of tDCS stimulation, 1x per day at 20 minutes per session, of up to 2mA. However, during sham stimulation (placebo) the current will not be active for the full 20 minutes

Sham tDCS

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals \> 60 years old, of both genders.
  • Diagnosis of primary knee osteoarthritis with chronic pain self-reported.
  • Be able to sign the informed consent to participate in the study.
  • Chronic pain (over the past 6 months) of at least 4 on a 0-10 VAS scale on average.
  • Reduction on VAS (visual analogic scale) during CPM (conditioned pain modulation) \< 10%

You may not qualify if:

  • Contraindications to transcranial brain stimulation, i.e. implanted brain medical devices or implanted brain metallic devices.
  • Severe acute or chronic decompensated disease.
  • Cognitive and behavioral impairment.
  • Epilepsy.
  • History of fractures in the lower limbs and/or spine in the last 6 months.
  • Use of carbamazepine within the past 6 months as self-reported.
  • Severe depression (with a score of \>30 in the Beck Depression Inventory)
  • History of syncope.
  • Traumatic brain injury with residual neurological deficits.
  • History of alcohol abuse within the past 6 months as self-reported.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Daniela Tavares

São Paulo, São Paulo, Brazil

Location

Related Publications (2)

  • Tavares DRB, Okazaki JEF, Santana MVA, Pinto ACPN, Tutiya KK, Gazoni FM, Pinto CB, Santos FC, Fregni F, Trevisani VFM. Motor cortex transcranial direct current stimulation effects on knee osteoarthritis pain in elderly subjects with dysfunctional descending pain inhibitory system: A randomized controlled trial. Brain Stimul. 2021 May-Jun;14(3):477-487. doi: 10.1016/j.brs.2021.02.018. Epub 2021 Mar 5.

  • Tavares DRB, Okazaki JEF, Rocha AP, Santana MVA, Pinto ACPN, Civile VT, Santos FC, Fregni F, Trevisani VFM. Effects of Transcranial Direct Current Stimulation on Knee Osteoarthritis Pain in Elderly Subjects With Defective Endogenous Pain-Inhibitory Systems: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2018 Oct 29;7(10):e11660. doi: 10.2196/11660.

MeSH Terms

Conditions

Osteoarthritis, KneeChronic PainOsteoarthritisMusculoskeletal Pain

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMuscular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Geriatrician

Study Record Dates

First Submitted

April 6, 2017

First Posted

April 17, 2017

Study Start

March 15, 2018

Primary Completion

June 1, 2019

Study Completion

July 1, 2019

Last Updated

September 9, 2019

Record last verified: 2019-09

Locations